Regulatory Alert: FDA's April 2026 Update on BPC 157 and GHK Cu Holt Law Injectable Peptides: Out of the Back Alley and Into the Light? Berkley Lifesciences The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics When will the FDA reclassify BPC 157 to Category 1? Odds & Predictions In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few Why would a patient trust a peptide more than a statin? STAT